Ruben Prieto Diaz

Rubén Prieto Díaz is a Postdoctoral Researcher at the Department of Organic Chemistry, University of Santiago de Compostela, affiliated with the Research Center in Biological Chemistry and Molecular Materials (CIQUS) and the Desinfarma research group focused on drug discovery and synthesis. His work centers on developing ligands targeting G protein-coupled receptors (GPCRs) for cancer immunotherapy and neuroprotection.

His doctoral thesis (2023) focused on the A2B adenosine receptor as a novel target in cancer immunotherapy under the supervision of Dr. Eddy Sotelo Pérez. His research spans structure-activity relationship (SAR) studies, multicomponent reaction strategies, and exploration of both orthosteric and allosteric receptor interactions.

Recent publications highlight his work on CB2 agonists for neuroprotection, IRAP inhibitors for neurological disorders, and antiplatelet agents. These studies emphasize conformational control, halogenation effects, and non-orthosteric interactions to enhance selectivity and therapeutic efficacy.

As a member of the Desinfarma group, his research contributes to advancing drug discovery pipelines through innovative synthetic approaches and receptor-targeting strategies. No specific scientific awards or student advisement details were disclosed in the provided materials.